Cargando…

A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes

Detalles Bibliográficos
Autores principales: Bouchi, Ryotaro, Kondo, Tatsuya, Ohta, Yasuharu, Goto, Atsushi, Tanaka, Daisuke, Satoh, Hiroaki, Yabe, Daisuke, Nishimura, Rimei, Harada, Norio, Kamiya, Hideki, Suzuki, Ryo, Yamauchi, Toshimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807160/
https://www.ncbi.nlm.nih.gov/pubmed/36562245
http://dx.doi.org/10.1111/jdi.13960
_version_ 1784862660256333824
author Bouchi, Ryotaro
Kondo, Tatsuya
Ohta, Yasuharu
Goto, Atsushi
Tanaka, Daisuke
Satoh, Hiroaki
Yabe, Daisuke
Nishimura, Rimei
Harada, Norio
Kamiya, Hideki
Suzuki, Ryo
Yamauchi, Toshimasa
author_facet Bouchi, Ryotaro
Kondo, Tatsuya
Ohta, Yasuharu
Goto, Atsushi
Tanaka, Daisuke
Satoh, Hiroaki
Yabe, Daisuke
Nishimura, Rimei
Harada, Norio
Kamiya, Hideki
Suzuki, Ryo
Yamauchi, Toshimasa
author_sort Bouchi, Ryotaro
collection PubMed
description
format Online
Article
Text
id pubmed-9807160
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98071602023-01-04 A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes Bouchi, Ryotaro Kondo, Tatsuya Ohta, Yasuharu Goto, Atsushi Tanaka, Daisuke Satoh, Hiroaki Yabe, Daisuke Nishimura, Rimei Harada, Norio Kamiya, Hideki Suzuki, Ryo Yamauchi, Toshimasa J Diabetes Investig Special Research Report John Wiley and Sons Inc. 2022-12-23 /pmc/articles/PMC9807160/ /pubmed/36562245 http://dx.doi.org/10.1111/jdi.13960 Text en © 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Special Research Report
Bouchi, Ryotaro
Kondo, Tatsuya
Ohta, Yasuharu
Goto, Atsushi
Tanaka, Daisuke
Satoh, Hiroaki
Yabe, Daisuke
Nishimura, Rimei
Harada, Norio
Kamiya, Hideki
Suzuki, Ryo
Yamauchi, Toshimasa
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes
title A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes
title_full A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes
title_fullStr A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes
title_full_unstemmed A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes
title_short A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes
title_sort consensus statement from the japan diabetes society: a proposed algorithm for pharmacotherapy in people with type 2 diabetes
topic Special Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807160/
https://www.ncbi.nlm.nih.gov/pubmed/36562245
http://dx.doi.org/10.1111/jdi.13960
work_keys_str_mv AT bouchiryotaro aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT kondotatsuya aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT ohtayasuharu aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT gotoatsushi aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT tanakadaisuke aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT satohhiroaki aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT yabedaisuke aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT nishimurarimei aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT haradanorio aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT kamiyahideki aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT suzukiryo aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT yamauchitoshimasa aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT aconsensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT bouchiryotaro consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT kondotatsuya consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT ohtayasuharu consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT gotoatsushi consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT tanakadaisuke consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT satohhiroaki consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT yabedaisuke consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT nishimurarimei consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT haradanorio consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT kamiyahideki consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT suzukiryo consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT yamauchitoshimasa consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes
AT consensusstatementfromthejapandiabetessocietyaproposedalgorithmforpharmacotherapyinpeoplewithtype2diabetes